CLINICAL_TRIALS
trial_result
· 2016-03-25
Clinical Trial Update: Evaluating Sirolimus to Treat Autoimmune Blistering Dermatosis Pemphigus [EARLY_Phase 1]
Summary
An early-phase 1 trial evaluating sirolimus for pemphigus was terminated, with results posted in 2016.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of California, Irvine | Conditions: Pemphigus | EARLY_Phase 1 | Status: TERMINATED | Results posted: 2016-03-25